Our scientists are focusing on the biology of epilepsy — and we’re making real progress. Here’s a look at what we’re developing for people living with epilepsy.
Ella the Jellyfish is the star of Eisai’s voice-enabled play and meditation skill. We created Ella to
bring comfort and support to those affected by Lennox-Gastaut syndrome (LGS). That’s what being a human
health care company is all about.
Meet Ella
Alexa is a trademark of Amazon.com, Inc or its affiliates.
It takes a total team effort from patients, their families and caregivers, health care professionals and companies like Eisai. That’s why we’ve made a substantial commitment to promoting epilepsy awareness and education.
Nearly 50% of people surveyed with epilepsy reported having a breakthrough convulsive seizure following a missed dose1,2. Breakthrough convulsive seizures come with significant risks to the patient3,4. A single missed dose may lead to a breakthrough seizure1,5. Nonadherence remains an obstacle3,5,6. Understand the risks and how to reduce them
Learn what people living with epilepsy and their caregivers revealed about this widely misunderstood disorder. See Improving Epilepsy Care
Medikidz® comic books use animated superheroes to explain medical conditions like epilepsy to children. learn more
Moving from pediatric to adult care can be a huge challenge for patients living with epilepsy. Here’s a step-by-step guide to making the transition. View infographic.
Living with LGS is an Eisai-sponsored educational site where you can learn about Lennox-Gastaut Syndrome from experts and other LGS families, view information-packed videos, explore treatment options and more. Visit Living with LGS
1Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002;3:338-342.
2A 10-item, nationwide postal survey of 661 patients conducted between 2001 and 2002.
3Devinsky O, Hesdorffer DC, Thurman DJ, et al. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15(10):1075-88.
4Devinsky O, Spruill T, Thurman D, et al. Recognizing and preventing epilepsy-related mortality: A call for action. Neurology. 2016;86(8):779-786.
5Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians. Epilepsy Behav. 2008;13(2):316-322.
6Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat. 2007;3(1):117-131.
